Regulatory

Intelligent Bio Solutions expands global reach with Drug Screening System upgrade

The enhanced system now supports multiple languages, improving accessibility for global drug screening operations....

QR678® Partners with Spectra Medical to Expand Access Nationwide

The partnership aims to make QR678®'s advanced, non-surgical hair regrowth treatment more accessible across the country through Spectra Medical’s distribution network. ...

Vertex Secures FDA Approval for JOURNAVX™ (suzetrigine), a Novel Non-Opioid Treatment for Acute Pain

JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....

Ryoncil® commercial launch progress and upcoming product pipeline developments

The latest updates on the market rollout of Ryoncil® and insights into the company’s expanding pipeline of innovative therapies....

Bicycle Health achieves profitability and secures $16.5M to expand Virtual Opioid use Disorder Treatment

The funding will help scale access to telehealth-based opioid use disorder care across the U.S., improving patient reach and support....

Spectral AI completes Pediatric enrollment for U.S. Burn Pivotal Study in Emergency Departments

The study aims to advance AI-driven burn assessment technology for improved pediatric patient outcomes....

Zimmer Biomet to acquire Paragon 28 in Definitive Agreement

The acquisition aims to strengthen Zimmer Biomet’s position in the foot and ankle surgery market with Paragon 28’s specialized solutions....

FDA Approves LEQEMBI® IV Maintenance Dosing for Early Alzheimer’s Treatment

Lecanemab-irmb receives approval as a maintenance therapy, offering new hope for early-stage Alzheimer’s patients....

Strengthening India’s Healthcare Backbone: CDSCO’s Policy on Refurbished Medical Devices Paves Way for Domestic Innovation and Patient Safety

India Takes Steps to Address Healthcare Security by Backing CDSCO's Ban on Pre-Owned Medical Device Imports Amid 70% Import Dependency...

Illuccix® Secures European Approval

Breakthrough imaging agent advances prostate cancer diagnostics across Europe....